How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care

Linnea M. Baudhuin, Leslie J. Donato, Timothy S. Uphoff

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Technological applications and novel biomarkers in the field of molecular diagnostics have never been evolving at a more rapid pace. These novel applications have the promise to change the face of clinical care as we move into the era of personalized medicine. While some of these technologies and biomarkers have been adopted by some clinical laboratories, most laboratories face a steep learning curve in bringing these dramatically new and different molecular diagnostic applications on board. Furthermore, interpreting the vast amounts and new types of data produced by these novel applications brings forth challenges for laboratorians and clinicians alike. In this article, we discuss how some of these emerging novel molecular diagnostic technologies and analytes, such as next-generation sequencing, chromosomal microarray, microRNAs and circulating fetal nucleic acids are revolutionizing patient care and personalized medicine.

Original languageEnglish (US)
Pages (from-to)25-37
Number of pages13
JournalExpert Review of Molecular Diagnostics
Volume12
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Molecular Pathology
Genetic Testing
Patient Care
Precision Medicine
Biomarkers
Technology
Learning Curve
MicroRNAs
Nucleic Acids

Keywords

  • array comparative genomic hybridization
  • cell-free nucleic acid
  • chromosomal microarray
  • circulating nucleic acid
  • companion diagnostics
  • fetal DNA
  • massively parallel sequencing
  • microRNA
  • miRNA
  • molecular diagnostics
  • next-generation sequencing
  • personalized medicine

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pathology and Forensic Medicine

Cite this

How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care. / Baudhuin, Linnea M.; Donato, Leslie J.; Uphoff, Timothy S.

In: Expert Review of Molecular Diagnostics, Vol. 12, No. 1, 01.2012, p. 25-37.

Research output: Contribution to journalReview article

Baudhuin, Linnea M. ; Donato, Leslie J. ; Uphoff, Timothy S. / How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care. In: Expert Review of Molecular Diagnostics. 2012 ; Vol. 12, No. 1. pp. 25-37.
@article{0cf7fd3022664503a585e0b03b5aaf4c,
title = "How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care",
abstract = "Technological applications and novel biomarkers in the field of molecular diagnostics have never been evolving at a more rapid pace. These novel applications have the promise to change the face of clinical care as we move into the era of personalized medicine. While some of these technologies and biomarkers have been adopted by some clinical laboratories, most laboratories face a steep learning curve in bringing these dramatically new and different molecular diagnostic applications on board. Furthermore, interpreting the vast amounts and new types of data produced by these novel applications brings forth challenges for laboratorians and clinicians alike. In this article, we discuss how some of these emerging novel molecular diagnostic technologies and analytes, such as next-generation sequencing, chromosomal microarray, microRNAs and circulating fetal nucleic acids are revolutionizing patient care and personalized medicine.",
keywords = "array comparative genomic hybridization, cell-free nucleic acid, chromosomal microarray, circulating nucleic acid, companion diagnostics, fetal DNA, massively parallel sequencing, microRNA, miRNA, molecular diagnostics, next-generation sequencing, personalized medicine",
author = "Baudhuin, {Linnea M.} and Donato, {Leslie J.} and Uphoff, {Timothy S.}",
year = "2012",
month = "1",
doi = "10.1586/erm.11.85",
language = "English (US)",
volume = "12",
pages = "25--37",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care

AU - Baudhuin, Linnea M.

AU - Donato, Leslie J.

AU - Uphoff, Timothy S.

PY - 2012/1

Y1 - 2012/1

N2 - Technological applications and novel biomarkers in the field of molecular diagnostics have never been evolving at a more rapid pace. These novel applications have the promise to change the face of clinical care as we move into the era of personalized medicine. While some of these technologies and biomarkers have been adopted by some clinical laboratories, most laboratories face a steep learning curve in bringing these dramatically new and different molecular diagnostic applications on board. Furthermore, interpreting the vast amounts and new types of data produced by these novel applications brings forth challenges for laboratorians and clinicians alike. In this article, we discuss how some of these emerging novel molecular diagnostic technologies and analytes, such as next-generation sequencing, chromosomal microarray, microRNAs and circulating fetal nucleic acids are revolutionizing patient care and personalized medicine.

AB - Technological applications and novel biomarkers in the field of molecular diagnostics have never been evolving at a more rapid pace. These novel applications have the promise to change the face of clinical care as we move into the era of personalized medicine. While some of these technologies and biomarkers have been adopted by some clinical laboratories, most laboratories face a steep learning curve in bringing these dramatically new and different molecular diagnostic applications on board. Furthermore, interpreting the vast amounts and new types of data produced by these novel applications brings forth challenges for laboratorians and clinicians alike. In this article, we discuss how some of these emerging novel molecular diagnostic technologies and analytes, such as next-generation sequencing, chromosomal microarray, microRNAs and circulating fetal nucleic acids are revolutionizing patient care and personalized medicine.

KW - array comparative genomic hybridization

KW - cell-free nucleic acid

KW - chromosomal microarray

KW - circulating nucleic acid

KW - companion diagnostics

KW - fetal DNA

KW - massively parallel sequencing

KW - microRNA

KW - miRNA

KW - molecular diagnostics

KW - next-generation sequencing

KW - personalized medicine

UR - http://www.scopus.com/inward/record.url?scp=82955189198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955189198&partnerID=8YFLogxK

U2 - 10.1586/erm.11.85

DO - 10.1586/erm.11.85

M3 - Review article

VL - 12

SP - 25

EP - 37

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 1

ER -